United Services Automobile Association Takes Position in Agilent Technologies, Inc. $A

Key Points

• United Services Automobile Association acquired a new position in Agilent Technologies, purchasing 6,845 shares valued at approximately $799,000 in the first quarter.
• Agilent Technologies reported earnings of $1.37 per share for Q3, meeting analysts' expectations, with revenue up 10.1% year-over-year at $1.74 billion.
• An average of six analysts rated Agilent Technologies as a "Moderate Buy," with a target price of $139.25, reflecting a mix of buy and hold opinions.

United Services Automobile Association bought a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 6,845 shares of the medical research company's stock, valued at approximately $799,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Vanguard Group Inc. grew its holdings in Agilent Technologies by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company's stock valued at $3,908,141,000 after buying an additional 240,965 shares in the last quarter. Pictet Asset Management Holding SA boosted its position in shares of Agilent Technologies by 2.5% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company's stock valued at $624,888,000 after acquiring an additional 128,131 shares during the last quarter. Generation Investment Management LLP grew its holdings in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after purchasing an additional 824,243 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Agilent Technologies by 9.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,231,981 shares of the medical research company's stock worth $434,184,000 after purchasing an additional 283,445 shares during the last quarter. Finally, Impax Asset Management Group plc raised its stake in Agilent Technologies by 3.6% during the first quarter. Impax Asset Management Group plc now owns 2,931,794 shares of the medical research company's stock valued at $342,961,000 after purchasing an additional 102,365 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $128.13 on Tuesday. The stock's fifty day moving average is $119.42 and its two-hundred day moving average is $116.00. The company has a market capitalization of $36.32 billion, a PE ratio of 30.08, a price-to-earnings-growth ratio of 4.00 and a beta of 1.24. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period last year, the company earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Analyst Ratings Changes

A has been the subject of a number of recent research reports. Evercore ISI dropped their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a research note on Thursday, August 28th. Wells Fargo & Company lifted their price target on Agilent Technologies from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Thursday, August 28th. TD Cowen boosted their price objective on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. UBS Group lowered their price objective on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research note on Thursday, May 29th. Finally, Leerink Partners lifted their target price on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a report on Friday, May 30th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $139.25.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at $4,397,893.12. This represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.